Q2 2024 Holdings
Filed 2024-08-13 | 44 holdings | $93.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Illumina Inc(ILMN) | COM | 452327109 | $12.4M | 119,196 | 13.3% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $11.1M | 368,665 | 11.9% |
| Merus N V | COM | N5749R100 | $7.1M | 120,038 | 7.6% |
| Geron Corp(GERN) | COM | 374163103 | $5.8M | 1,373,550 | 6.2% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $5.2M | 436,378 | 5.6% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.5M | 74,022 | 4.8% |
| Exscientia PLC | ADS | 30223G102 | $4.4M | 859,892 | 4.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.2M | 106,680 | 4.4% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $3.9M | 144,570 | 4.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $3.6M | 106,100 | 3.9% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $3.3M | 1,883,179 | 3.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $3.3M | 23,022 | 3.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.6M | 219,277 | 2.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.0M | 49,120 | 2.2% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $1.9M | 146,800 | 2.0% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $1.9M | 493,584 | 2.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.9M | 13,600 | 2.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $1.8M | 204,939 | 2.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.7M | 102,984 | 1.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $1.6M | 5,682 | 1.7% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.4M | 64,200 | 1.5% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $953.2K | 55,000 | 1.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $890.4K | 10,815 | 0.9% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $875.2K | 1,166,952 | 0.9% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $699.4K | 49,082 | 0.7% |
| Athira Pharma Inc | COM | 04746L104 | $477.0K | 180,000 | 0.5% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $376.0K | 274,488 | 0.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $352.7K | 47,150 | 0.4% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $350.2K | 17,300 | 0.4% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $343.2K | 32,470 | 0.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $324.6K | 10,875 | 0.3% |
| Grail Inc(GRAL) | COM | 384747101 | $305.3K | 19,866 | 0.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $283.3K | 7,300 | 0.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $280.6K | 7,450 | 0.3% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $253.0K | 41,950 | 0.3% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $228.8K | 6,750 | 0.2% |
| Affimed N V | ORDINARY SHS NEW | N01045207 | $203.0K | 37,247 | 0.2% |
| Immatics N.v(IMTX) | SHS | N44445109 | $182.4K | 15,700 | 0.2% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $180.0K | 40,000 | 0.2% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $150.9K | 50,971 | 0.2% |
| DBV Technologies S A | SPONSORED ADR | 23306J200 | $148.6K | 185,475 | 0.2% |
| Aerovate Therapeutics Inc | COM | 008064107 | $79.6K | 47,936 | 0.1% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $75.0K | 31,922 | 0.1% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $55.4K | 62,106 | 0.1% |